USPTO serial 79447759
Serial No. 79447759
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with Serial No. 79447759?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Transdermal patches; skin patches and adhesive skin patches for medical use; transdermal patches and adhesive skin patches for treating, relieving or preventing the development or progression of allergies or immunological disorders; transdermal patches and adhesive skin patches for transdermal administration of pharmaceuticals or medical preparations; epicutaneous systems or patches for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; epicutaneous systems or patches containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; epicutaneous systems or patches intended for the treatment of allergies or immunological disorders; epicutaneous systems or patches containing allergens or antigens to treat allergies or immunological disorders; medicines against allergies; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts for the aforesaid goods; skin compresses intended for receiving, maintaining or containing medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; skin compresses intended for use in medical training; skin compresses for medical use, namely intended for use in training healthcare professionals on the transdermal administration of pharmaceuticals or medical preparations. | ACTIVE | — |
| 010 | Medical devices, apparatus and instruments for cutaneous or epicutaneous administration or delivery, or administration or delivery via a patch, of medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; skin patches intended for receiving, maintaining or containing medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; skin patches intended for use in medical training; skin patches for medical use, namely intended for use in training healthcare professionals on the transdermal administration of pharmaceuticals or medical preparations; medical devices, apparatus and instruments sold without medication for the subsequent cutaneous or epicutaneous administration of medical or pharmaceutical substances; dispensers and applicators for compresses, skin patches and occlusion patches for medical use; parts for the aforesaid goods. | ACTIVE | — |
| 041 | Education and training services for consumers and professionals in the field of allergies and immunotherapy: organization of courses, seminars, programs, conferences, congresses, workshops in the field of allergies and immunotherapy; online educational exhibition services featuring interactive displays and exhibits in the field of allergies and immunotherapy; publication of periodicals, books, guides and databases in the field of allergies and immunotherapy; information, advisory and consultancy services relating to the aforementioned services. | ACTIVE | — |
| 042 | Medical and scientific research services in the field of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, relief and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergen drug research services; medical and scientific research services, namely development of methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely development of methods for treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to the skin of patients; information, advisory and consultancy services relating to the aforementioned services. | ACTIVE | — |
| 044 | Medical services relating to the treatment, relief and prevention of allergies; medical treatment, relief and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical or pharmaceutical substances, allergens or antigens using patches affixed to the skin of patients; medical consultancy in the field of desensitization to allergies; information, advisory and consultancy services relating to the aforementioned services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2026 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jun 25, 2026 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| May 14, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 6, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |